Thalidomide E3 ubiquitin ligase inhibitor Thalidomide inhibits TNFα production by stimulated human monocytes and induces monocyte apoptosis. It costimulates primary human T lymphocytes and inhibits angiogenesis. Thalidomide is finding applications in various immunologic diseases such as Crohn's disease and in angiogenesis-dependent diseases. Product Specification Formula: C13H10N2O4 MW: 258.2 CAS: 50-35-1 Purity: ≥99% (HPLC) Appearance: White solid Hazard: HARMFUL. TERATOGENIC Solubility: Soluble in DMSO (>25 mg/ml). Long Term Storage: Ambient